Aurora-A overexpression in mouse liver causes p53-dependent premitotic arrest during liver regeneration

Molecular Cancer Research

Volumn 7, Issue 5, 2009, Pages 678-688

  Li, Chao Chin ^a,c   Chu, Hui Yi ^a   Yang, Chu Wen ^b   Chou, Chen Kung ^d   Tsai, Ting Fen ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SOOCHOW UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIVISION; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINESIS; DNA SYNTHESIS; EMBRYO; FETUS; INCIDENCE; KNOCKOUT GENE; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; FEMALE; G2 PHASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; S PHASE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 66349129660     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0483     Document Type: Article

References (44)

1. Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of poles. Nat Rev Cancer 2005;5:42-50. (Pubitemid 40052324)
2. Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 2005;15:241-250
3. Kufer TA, Sillje HH, Korner R, Gruss OJ, Meraldi P, Nigg EA. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002;158:617-623
4. Hirota T, Kunitoku N, Sasayama T, et al. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 2003;114:585-598 (Pubitemid 37159255)
5. Hutterer A, Berdnik D, Wirtz-Peitz F, Zigman M, Schleiffer A, Knoblich JA. Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev Cell 2006;11:147-157 (Pubitemid 44138495)
6. Honda K, Mihara H, Kato Y, et al. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway. Oncogene 2000;19:2812-2819 (Pubitemid 30386417)
7. Castro A, Arlot-Bonnemains Y, Vigneron S, Labbe JC, Prigent C, Lorca T. APC/Fizzy-related targets Aurora-A kinase for proteolysis. EMBO Rep 2002;3:457-462 (Pubitemid 34567434)
8. Lim SK, Gopalan G. Antizyme1mediates AURKAIP1-dependent degradation of Aurora-A. Oncogene 2007;26:6593-6603
9. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002;21:483-492 (Pubitemid 34174030)
10. Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003;3:51-62. (Pubitemid 37443890)
11. 2 checkpoint in mammalian cells. Genes Cells 2002;7:1173-1182
12. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998;17:3052-3065 (Pubitemid 28254378)
13. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-193 (Pubitemid 28455454)
14. Chen SS, Chang PC, Cheng YW, Tang FM, Lin YS. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO J 2002;21:4491-4499 (Pubitemid 34984336)
15. Katayama H, Sasai K, Kawai H, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004;36:55-62. (Pubitemid 38056208)
16. Liu Q, Kaneko S, Yang L, et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J Biol Chem 2004;279:52175-52182 (Pubitemid 39656591)
17. Zhang D, Hirota T, Marumoto T, et al. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 2004;23:8720-8730 (Pubitemid 39593287)
18. Wang X, Zhou YX, Qiao W, et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 2006;25:7148-7158 (Pubitemid 44764184)
19. Smith MW, Yue ZN, Geiss GK, et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003;63:859-864 (Pubitemid 36231988)
20. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004;10:2065-2071 (Pubitemid 38375568)
21. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43:S45-53. (Pubitemid 43303968)
22. Leu JI, Crissey MA, Craig LE, Taub R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP β and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 2003;23:1251-1259 (Pubitemid 36177035)
23. Li W, Liang X, Kellendonk C, Poli V, Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411-28417 (Pubitemid 41079264)
24. Greenbaum LE, Li W, Cressman DE, et al. CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998;102:996-1007. (Pubitemid 28419244)
25. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446 (Pubitemid 27087870)
26. Fukuda T, Mishina Y, Walker MP, DiAugustine RP. Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol Cell Biol 2005;25:5270-5281 (Pubitemid 40781123)
27. Tanaka M, Ueda A, Kanamori H, et al. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 2002;277:10719-10726 (Pubitemid 34968200)
28. Hoque A, Carter J, Xia W, et al. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev 2003;12:1518-1522 (Pubitemid 38031757)
29. Sieber O, Heinimann K, Tomlinson I. Genomic stability and tumorigenesis. Semin Cancer Biol 2005;15:61-66 (Pubitemid 40018529)
30. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-785 (Pubitemid 41400777)
31. 1. Mol Biol Cell 2001;12:1315-1328
32. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998;18:1055-1064 (Pubitemid 28063440)
33. 1 arrest. Cancer Res 1998;58:396-401.
34. Ewart-Toland A, Briassouli P, de Koning JP, et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003;34:403-412 (Pubitemid 36935333)
35. Ewart-Toland A, Dai Q, Gao YT, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 2005;26:1368-1373 (Pubitemid 41417879)
36. Li CC, Chou CK, Wang MH, Tsai TF. Overexpression of ABIN-2, a negative regulator of NF-κB, delays liver regeneration in the ABIN-2 transgenic mice. Biochem Biophys Res Commun 2006;342:300-309 (Pubitemid 43247391)
37. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo: a laboratory manual. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1994.
38. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2001.
39. National Research Council. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press; 1996.
40. Higgins GM, Anderson RM. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
41. Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003;16:99-102. (Pubitemid 36609041)
42. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7. (Pubitemid 2027671)
43. Harlow E, Lane D. Using antibodies: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1999.
44. Young B, Heath JW. Wheater's functional histology: a text and colour atlas. 4th ed. Churchill Livingstone: Elsevier Science Limited; 2002.